CytoMed Therapeutics Limited Ordinary Shares
Symbol: GDTC (NASDAQ)
2.47
▲ (1.69%) 0.041
Company Description:
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Key Stats
- Today's Open: $2.33
- Today's High: $2.565
- Today's Low: $2.325
- Today's Volume: 32.20K
- Yesterday Close: $2.43
- Yesterday High: $2.65
- Yesterday Low: $2.32
- Yesterday Volume: 75.75K
- Last Min Volume: 100
- Last Min High: $2.487
- Last Min Low: $2.471
- Last Min VWAP: $2.487
Company Profile
- Name: CytoMed Therapeutics Limited Ordinary Shares
- Website: https://w2.cytomed.sg
- Listed Date: 2023-04-14
- Location: ,
- Market Status: Active
- CIK Number: 0001873093
- SIC Code:
- SIC description:
- Market Cap: $28.51M
- Round Lot: 100
- Outstanding Shares: 11.73M
- Asset Type: CS
RECENT FILINGS FOR GDTC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-22 | 6-K | View |
| 2025-10-14 | 6-K | View |
| 2025-10-02 | 6-K | View |
| 2025-09-30 | 6-K | View |
| 2025-09-22 | 144 | View |
| 2025-08-28 | 6-K | View |
| 2025-08-19 | 6-K | View |
| 2025-08-18 | 424B5 | View |
| 2025-07-21 | 6-K | View |
| 2025-07-03 | 6-K | View |
| 2025-07-03 | 6-K | View |
| 2025-06-23 | EFFECT | View |
| 2025-06-23 | 144 | View |
| 2025-06-20 | CORRESP | View |
| 2025-06-18 | UPLOAD | View |
| 2025-06-13 | F-3 | View |
| 2025-05-16 | 6-K | View |
| 2025-04-28 | 6-K | View |
| 2025-04-28 | 20-F | View |
| 2025-03-24 | 144 | View |
Latest News on GDTC